Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sperm acrosome membrane-associated protein 1 (SPACA1) is a glycosylated, integral membrane protein localized specifically to the acrosomal membrane of spermatids and mature spermatozoa. It is essential for proper acrosome formation, sperm head shaping, and ultimately for successful sperm-egg fusion during fertilization. Loss-of-function or knockout of SPACA1 in mice results in infertility due to abnormal sperm morphology reminiscent of human globozoospermia, implicating this gene in certain types of human male infertility. Its primary biological expression is in the testis, and its dysfunction correlates strongly with defective spermatogenesis and morphological sperm defects. There is no evidence that SPACA1 is directly targeted by any approved or investigational drugs, nor is it an established therapeutic target in any other disease area.
Not applicable (No drugs are known to target this protein; mechanisms of action are not defined)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sperm acrosome membrane-associated protein 1 (SPACA1).